Michael Truett Tate Sells 12,001 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) CFO Michael Truett Tate sold 12,001 shares of Astera Labs stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares in the company, valued at approximately $23,781,796.23. This represents a 5.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Astera Labs Stock Down 2.2%

Astera Labs stock opened at $129.68 on Friday. The firm has a 50 day moving average price of $160.40 and a 200-day moving average price of $174.06. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The company has a market capitalization of $21.90 billion, a P/E ratio of 106.30, a P/E/G ratio of 2.61 and a beta of 1.50.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The business had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. During the same quarter in the prior year, the business earned $0.37 earnings per share. Astera Labs’s revenue for the quarter was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on ALAB shares. BNP Paribas Exane began coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating on the stock. Wall Street Zen cut shares of Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Citigroup cut their price objective on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. Morgan Stanley reissued an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a report on Wednesday, December 3rd. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Fourteen research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $192.89.

Read Our Latest Report on Astera Labs

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
  • Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
  • Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
  • Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
  • Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
  • Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
  • Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
  • Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of ALAB. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after purchasing an additional 84,365 shares during the period. State Street Corp grew its position in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares in the last quarter. Geode Capital Management LLC increased its stake in Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after acquiring an additional 104,935 shares during the last quarter. Fred Alger Management LLC raised its holdings in shares of Astera Labs by 25.5% in the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after acquiring an additional 393,250 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of Astera Labs by 33.0% during the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after acquiring an additional 480,009 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Recommended Stories

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.